Evanson Jeff
- SEC CIK
- 0001760511
No open-market purchases or sales filed in the past year.
Current role at each company
- OTLK Outlook Therapeutics, Inc.CHIEF COMMERCIAL OFFICERas of Mar 22, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Evanson Jeff as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 (view filing)4:43 PM ET | Mar 7 | 4 days | Evanson JeffCHIEF COMMERCIAL OFFICER | PPurchase | +62.5K | $0.42 | +$26.2K | +8.4%808.5K after | |
| Jan 24, 2023 (view filing) | Jan 20 | 4 days | Evanson JeffChief Commercial Officer | SSale | −267.0K | $1.11 | −$296.4K | −26.4%746.0K after | |
| Jan 19, 2023 (view filing) | Jan 17-19 | 2 days | Evanson JeffChief Commercial Officer | SSale | −164.2K | $1.24 | −$203.7K | −13.9%1.01M after | 3 lots |
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Evanson JeffChief Commercial Officer | PPurchase | +35.2K | $1.34 | +$47.2K | +3.1%1.18M after |